{"id":"W3200915536","doi":"10.1016/j.kint.2021.09.005","title":"A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function","year":2021,"lang":"en","type":"article","venue":"Kidney International","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"Janssen Pharmaceuticals; Novo Nordisk Fonden; Relypsa; Cytokinetics; Astellas Pharma; Satellite Healthcare; University of Glasgow; Bristol-Myers Squibb; Akebia Therapeutics; Steno Diabetes Center Copenhagen; Novo Nordisk; ReCor Medical; Eli Lilly and Company; AstraZeneca; CSL Behring; Alnylam Pharmaceuticals; Gilead Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; Sanofi; GlaxoSmithKline; Defense Acquisition Program Administration; Amgen; Angion; Pfizer","keywords":"Kidney disease; Dapagliflozin; Medicine; Renal function; Incidence (geometry); Adverse effect; Randomized controlled trial; Internal medicine; Intensive care medicine; Acute kidney injury; Endocrinology; Diabetes mellitus; Type 2 diabetes","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009601291,0.002393134,0.00456282,0.0007791671,0.0004082234,0.001549048,0.00102834,0.002668057,0.007443827],"category_scores_gemma":[0.01272547,0.0008296434,0.008989898,0.0005985436,0.0009649727,0.0009636079,0.0005690978,0.004424364,0.0008933163],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007507309,"about_ca_system_score_gemma":0.001617095,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007338669,"about_ca_topic_score_gemma":0.001912994,"domain_scores_codex":[0.9919818,0.005831665,0.0005150774,0.0005931699,0.0005890205,0.000489247],"domain_scores_gemma":[0.9933073,0.004201741,0.001053703,0.0004469264,0.0004762752,0.0005141161],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9786108,0.000906312,0.001097986,0.002178247,0.006521067,0.00006138841,0.00002812668,0.0004807161,0.001173132,0.0003177303,0.00162248,0.007001987],"study_design_scores_gemma":[0.9623525,0.02314956,0.003517583,0.00009608932,0.007071068,0.00004198736,0.00001046092,0.001081385,0.0008544736,0.000397993,0.001401496,0.00002547646],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8435993,0.03454889,0.01882934,0.004728887,0.004464651,0.05659427,0.01995928,0.0009882869,0.01628712],"genre_scores_gemma":[0.9541492,0.003992579,0.007584249,0.002843772,0.0009099229,0.02115909,0.004794426,0.00008145407,0.004485233],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009601291,"threshold_uncertainty_score":0.05077714,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01539465636533565,"score_gpt":0.2914013133539956,"score_spread":0.2760066569886599,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}